Human chorionic gonadotropin (hCG) is a peptide hormone which plays an important role during pregnancy. But its impact is not limited to pregnancy; it also influences tumor formation and metastatic outgrowth, especially in endometrial adenocarcinoma and breast cancer. This review summarizes what has been written in the literature about the role of hCG as a tumor marker in these 2 gynecological malignancies and also about the signal transduction pathways in which hCG is involved. HCG can, on the one hand, be a marker for the progression of a malignant disease, and on the other hand, it may be a point for therapeutical intervention, so further research into this molecule would be very much worthwhile.
CITATION STYLE
Kölbl, A. C., Schlenk, K., Behrendt, N., & Andergasse, U. (2018). The importance of hcg in human endometrial adenocarcinoma and breast cancer. International Journal of Biological Markers, 33(1), 33–39. https://doi.org/10.5301/ijbm.5000290
Mendeley helps you to discover research relevant for your work.